Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2012
11/28/2012CN102803225A Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/28/2012CN102802731A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN102802730A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN101723901B Method for preparing 2-propylbenzimidazole
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/22/2012WO2012157821A1 Variable color two-photon fluorescent probe, method for imaging thiol activation in mitochondrion using same, and method for manufacturing the variable color two-photon fluorescent probe
11/22/2012WO2012109354A3 Crystalline explosive material
11/22/2012US20120292601 Phosphorescent heteroleptic phenylbenzimidazole dopants and new synthetic methodology
11/22/2012DE112010004188T5 Metallkomplex mit mehrzähnigem Liganden Metal complex with multidentate ligands
11/21/2012EP2524913A1 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
11/21/2012CN102792777A Method for producing organic electroluminescence element
11/21/2012CN102791696A Amino alcohol derivatives and their therapeutic activities
11/21/2012CN101845006B Beta-alkyl sulfide substituted vinyl propionate sulfur compound and preparation method thereof
11/21/2012CN101838244B Organic solvent synthetic method of azoic coupling component ASBI
11/21/2012CN101128452B Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same
11/20/2012US8314253 Bridged tetrahydronaphthalene derivatives
11/20/2012US8314135 Linked dibenzimidazole antivirals
11/20/2012US8314134 Compounds for inflammation and immune-related uses
11/20/2012US8314097 Organic compounds
11/20/2012CA2533763C Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
11/15/2012WO2012152855A1 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
11/15/2012US20120289705 Compound having hydantoin ring and method of producing the same
11/14/2012EP2522662A1 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
11/14/2012CN102781911A Latent acids and their use
11/14/2012CN102775355A Preparation method of 2-hydroxybenzimidazole
11/13/2012US8309581 Benzimidazole derivatives
11/08/2012US20120283287 Certain chemical entities, compositions, and methods
11/07/2012EP2519507A1 Amino alcohol derivatives and their therapeutic activities
11/07/2012CN102770414A [5,6] heterocyclic compound
11/07/2012CN101166719B Bcrp/abcg2 inhibitor
11/01/2012WO2012147765A1 Benzimidazole derivative having npy y5 receptor antagonist action
11/01/2012WO2012108689A3 Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor
11/01/2012WO2012088100A3 Triclabendazole and fenbendazole for cell protection
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277258 Chemical Compounds
11/01/2012US20120276050 Methods and compositions of treating a flaviviridae family viral infection
10/2012
10/31/2012EP2516404A2 Preparation of bendamustine and its salts
10/31/2012CN102757423A Exo- and diastereo- selective syntheses of himbacine analogs
10/31/2012CN102757389A 雄激素受体拮抗剂及其用途 Androgen receptor antagonists and their use
10/31/2012CN101287712B Heterocyclic compounds
10/30/2012US8299269 Nor-seco-bis-nor-seco, tris-nor-seco, and higher nor-seco-cucurbit[n]uril compounds
10/30/2012US8299110 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors
10/30/2012US8299061 Inhibitors of diacylglycerol acyltransferase
10/26/2012WO2012116010A3 Antibiotic tolerance inhibitors
10/25/2012US20120270071 Chromene compound
10/24/2012EP2514745A1 GPR120 receptor agonists and uses thereof
10/24/2012EP2513054A1 Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012CN102753524A Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012CN102746236A Method for preparing functionalized graphene oxide
10/23/2012US8293780 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making
10/23/2012US8293774 Optically active (R)-aryloxypropionic acid amides and herbicidal composition comprising same
10/18/2012WO2012139212A1 Preparation and use of pseudopteroxazole and pseudopterosin analogs and derivatives
10/18/2012US20120264760 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
10/17/2012EP2511264A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/17/2012CN102731408A Azilsartan intermediate and preparation method thereof
10/17/2012CN102731407A Method for preparing telmisartan
10/17/2012CN102731406A Phenanthroimidazole derivatives and application of phenanthroimidazole derivatives in preparation of electroluminescent device
10/16/2012US8288425 Benzimidazoles
10/11/2012WO2012136492A1 Wnt pathway antagonists
10/11/2012US20120258992 Dual-acting antihypertensive agents
10/11/2012CA2832305A1 Wnt pathway antagonists
10/10/2012EP2507229A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/10/2012EP2507211A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/10/2012CN102718718A Preparation method for 3,5-dibromo-4-(5-benzimidazole oxygen group)phenylacetic acid
10/10/2012CN101479249B Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same
10/10/2012CN101142194B Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
10/09/2012CA2551788C Novel carboxamides for use as xa inhibitors
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012WO2012131501A1 Substituted benzimidazole compounds as cot kinase inhibitors
10/04/2012WO2012130905A1 Substituted benzimidazoles
10/04/2012US20120253049 Novel hydrogen sulfate salt
10/04/2012CA2831710A1 Substituted benzimidazoles as mps-1 kinase inhibitors
10/03/2012CN102712601A A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
10/03/2012CN102702173A Method for preparing sulfur ether intermediates of proton pump inhibitor
10/03/2012CN102127021B Preparation method of water-soluble amino acid-derived bisbenzimidazole salt
10/03/2012CN101948436B Method for preparing high-purity bendamustine hydrochloride
10/03/2012CN101397276B Dibenzimidazole and onium compound thereof, preparation method and medical use thereof
10/02/2012US8278460 Substituted benzimidazoles
10/02/2012US8278459 UV-filter compounds
10/02/2012CA2666489C Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
10/02/2012CA2372746C Imidazolidine-based metal carbene metathesis catalysts
09/2012
09/27/2012WO2012129258A1 Amidopyrazole inhibitors of interleukin receptor-associated kinases
09/27/2012WO2012059442A3 Neurotrypsin inhibitors
09/27/2012US20120244208 Cosmetic skin care methods and compositions
09/26/2012EP2502903A1 Process for producing 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative and intermediate thereof
09/26/2012CN102688250A Synthesis and application of azo derivatives as inhibitor of RSK2
09/26/2012CN102082230B Infrared organic electroluminescent device
09/26/2012CN101508682B Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/26/2012CN101119965B Tetralin and indane derivatives and uses thereof
09/25/2012CA2667481C New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
09/20/2012WO2012124820A1 Metal complex and organic electronic element containing said metal complex
09/20/2012WO2012123888A1 Terrylene compounds, preparation thereof and use thereof in organic solar cells
09/20/2012WO2012123287A1 Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives
09/20/2012WO2012122891A1 Oxime-containing amino derivative, pharmaceutical composition, preparation method and use thereof
09/20/2012US20120238763 Process for producing 3-alkoxy-2-amino-6-fluorobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative and intermediate thereof
09/20/2012US20120238611 Dual-acting benzoimidazole antihypertensive agents
09/19/2012EP2499117A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
09/19/2012EP2499114A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds
09/19/2012CN102675212A N-substituted phenyl-2-((1H-benzimidazole-2-group) sulfydryl) amides derivatives and usage thereof
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 154